Launch · Healthcare & Life Sciences

Kapiva launches ₹50 Cr innovation fund for ayurveda research

By Startup Enthusiast · 26 February 2026

What they do

Kapiva launched a ₹50 Cr innovation fund for ayurvedic research and new product development

The fund will back research institutions, PhD scholars, hospitals, labs, and startups

It will support clinically tested solutions and AI in Ayurveda, with capital from its last fundraise

Kapiva launched an innovation fund worth ₹50 Cr for ayurveda research.
The fund will back projects from research institutions, PhD scholars, hospitals, labs, and startups.
It will focus on ayurvedic research, new product development, and AI in Ayurveda.
The fund will support clinically tested solutions for real health problems.
Early-stage research projects can get up to ₹50 Lakh each.
Late-stage research projects can get ₹4-6 Cr each.
Applications open from 26 February 2026.
Kapiva will offer access to in-house experts and expand its R&D facility in Bengaluru.

Many researchers and startups lack resources to build better ayurvedic products.
Demand for natural and herbal wellness products is rising in India.
The Indian ayurvedic products market is expected to reach ₹3.21 Lakh Cr by 2032, growing at 17% CAGR.

Kapiva sells ayurvedic nutrition and wellness products: supplements, gummies, capsules, and skincare.
It offers over 100 products.
It provides consultations with ayurvedic doctors.
Top categories include diabetes care, gym and sports nutrition, energy, and liver and heart health.
Its highest-selling segment is the diabetes supplement category.
Sales channels include its own D2C website, online marketplaces, and offline retail stores.

Product: D2C ayurveda brand
Customers: Consumers seeking evidence-based ayurvedic nutrition and wellness products
How it makes money: Direct-to-consumer brand selling ayurvedic supplements, gummies and skincare online
What sets it apart: Modern positioning of ayurveda with clinical validation and wide retail reach